Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Brady

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Mabs|September 16, 2020
Targeted IgMs agonize ocular targets with extended vitreal exposureYvonne Chen, Maciej Paluch, Julie A Zorn, et al.
Cancer Research|November 17, 2005
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovaryTomas Bonome, Ji-Young Lee, Dong-Choon Park, et al.
Behavioral and Brain Functions : BBF|June 30, 2011
Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B &NTRK2 polymorphismsTherese M Murphy, Maria Ryan, Tom Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2015
Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic ModulationJessica A Couch, Gu Zhang, Joseph C Beyer, et al.
Cancer Cell|December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Mabs|September 16, 2020
Targeted IgMs agonize ocular targets with extended vitreal exposureYvonne Chen, Maciej Paluch, Julie A Zorn, et al.
Cancer Research|November 17, 2005
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovaryTomas Bonome, Ji-Young Lee, Dong-Choon Park, et al.
Behavioral and Brain Functions : BBF|June 30, 2011
Risk and protective genetic variants in suicidal behaviour: association with SLC1A2, SLC1A3, 5-HTR1B &NTRK2 polymorphismsTherese M Murphy, Maria Ryan, Tom Foster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2015
Balancing Efficacy and Safety of an Anti-DLL4 Antibody through Pharmacokinetic ModulationJessica A Couch, Gu Zhang, Joseph C Beyer, et al.
Cancer Cell|December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Pageof 5